We collected information about Keros Therapeutics Hours for you. Follow the liks to find out everything about Keros Therapeutics Hours.
Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from rare hematologic and musculoskeletal disorders with high unmet medical need. ... Keros Therapeutics. 99 Hayden Avenue Suite 120, Building E Lexington, MA 02421
https://www.nasdaq.com/market-activity/stocks/kros/after-hours
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET).
https://www.kerostx.com/contact-us/
Keros Therapeutics 99 Hayden Avenue Suite 120, Building E Lexington, MA 02421 +1 (617) 314-6297. Name * First Name. Last Name. Email * Subject * Message * Thank you! Directions. From Boston/Cambridge Take Rt 2 to exit 54B and turn Left on Hayden Ave. Go down the street (~0.3 miles) and enter the driveway on your right for 99 Hayden. ...
https://www.marketbeat.com/instant-alerts/nasdaq-kros-options-data-report-2021-12/
4 hours ago · Keros Therapeutics, Inc. (NASDAQ:KROS) saw a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 788,200 shares, a drop of 22.0% from the October 31st total of 1,010,000 shares. Currently, 5.7% of the shares of the stock are short sold. Based on an average trading volume of 189,500 shares, the days-to-cover …
https://www.marketbeat.com/instant-alerts/nasdaq-kros-gap-down-2021-11-2-3/
Based on data from MarketBeat.com, Keros Therapeutics currently has a consensus rating of "Buy" and an average target price of $77.00. The stock's 50-day moving average price is $39.49 and its 200-day moving average price is $42.86. The company has a market cap of $1.39 billion, a P/E ratio of -22.83 and a beta of 1.55.
https://www.cnbc.com/quotes/KROS
Keros Therapeutics Inc. KROS. : NASDAQ. WATCHLIST +. RT Quote | Last NASDAQ LS, VOL From CTA | USD. After Hours: Last | 10/29/21 EDT. 41.72 UNCH (UNCH)
https://www.barrons.com/market-data/stocks/kros
Complete Keros Therapeutics Inc. stock information by Barron's. View real-time KROS stock price and news, along with industry-best analysis. ... After Hours Vol. 563. Price at close $59.41-0.05-0 ...
https://nz.news.yahoo.com/keros-therapeutics-present-piper-sandler-130000993.html
LEXINGTON, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced …
Searching for Keros Therapeutics Hours?
You can just click the links above. The info is collected for you.
